BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35260638)

  • 1. YB1 associates with oncogenetic roles and poor prognosis in nasopharyngeal carcinoma.
    Zhan Y; Chen X; Zheng H; Luo J; Yang Y; Ning Y; Wang H; Zhang Y; Zhou M; Wang W; Fan S
    Sci Rep; 2022 Mar; 12(1):3699. PubMed ID: 35260638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.
    Zhou K; Zhao J; Xu H; Yan X; Liu W; Jiang X; Ren C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):685-697. PubMed ID: 35837768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of abnormal expression of CD73 on malignant phenotype of nasopharyngeal carcinoma.
    Jiang B; Tang M; Shi S; Xie H; Pan S; Zhang L; Sheng J
    J Mol Histol; 2023 Dec; 54(6):633-644. PubMed ID: 37874500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced CTGF expression promotes cell growth, migration, and invasion in nasopharyngeal carcinoma.
    Zhen Y; Ye Y; Yu X; Mai C; Zhou Y; Chen Y; Yang H; Lyu X; Song Y; Wu Q; Fu Q; Zhao M; Hua S; Wang H; Liu Z; Zhang Y; Fang W
    PLoS One; 2014; 8(6):e64976. PubMed ID: 23755163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma.
    Xu YF; Ren XY; Li YQ; He QM; Tang XR; Sun Y; Shao JY; Jia WH; Kang TB; Zeng MS; Liu N; Ma J
    BMC Cancer; 2015 Apr; 15():332. PubMed ID: 25925041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
    Zheng YQ; Bai YF; Yang S; Cui YR; Wang YP; Hu WL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of G3BP1 associates with YB1 and p-AKT and predicts poor prognosis in nonsmall cell lung cancer patients after surgical resection.
    Zheng H; Zhan Y; Zhang Y; Liu S; Lu J; Yang Y; Wen Q; Fan S
    Cancer Med; 2019 Nov; 8(16):6894-6903. PubMed ID: 31560169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIMP2-DX2 Promotes the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells.
    Cao Q; Zhang J; Zhang T
    Biomed Res Int; 2018; 2018():9253036. PubMed ID: 29854811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXD1, negatively regulated by miR-186, promotes the proliferation, metastasis and radioresistance of nasopharyngeal carcinoma cells.
    Zhang Y; Zhang W
    Cancer Biomark; 2020; 28(4):511-521. PubMed ID: 32568181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression of SETDB1 possesses prognostic value and promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma.
    Huang J; Huang W; Liu M; Zhu J; Jiang D; Xiong Y; Zhen Y; Yang D; Chen Z; Peng L; Yu Z
    Oncol Rep; 2018 Aug; 40(2):1017-1025. PubMed ID: 29901162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
    FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TMEM130 regulates cell migration through DNA methylation in nasopharyngeal carcinoma.
    Liu H; Zhang Y; Chen W; Zhang Y; Zhang W
    Cancer Biomark; 2022; 34(2):265-273. PubMed ID: 34958002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein tyrosine kinase 6 is associated with nasopharyngeal carcinoma poor prognosis and metastasis.
    Liu LN; Huang PY; Lin ZR; Hu LJ; Liang JZ; Li MZ; Tang LQ; Zeng MS; Zhong Q; Zeng BH
    J Transl Med; 2013 Jun; 11():140. PubMed ID: 23758975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA UCA1 affects epithelial-mesenchymal transition, invasion, migration and apoptosis of nasopharyngeal carcinoma cells.
    Han R; Chen S; Wang J; Zhao Y; Li G
    Cell Cycle; 2019 Nov; 18(21):3044-3053. PubMed ID: 31537148
    [No Abstract]   [Full Text] [Related]  

  • 15. High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma.
    Zhou J; Zhang J; Xu M; Ke Z; Zhang W; Mai J
    PLoS One; 2019; 14(4):e0215299. PubMed ID: 30973923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of macrophage migration inhibitory factor and DJ-1 contribute to cell invasion and metastasis of nasopharyngeal carcinoma.
    Pei XJ; Wu TT; Li B; Tian XY; Li Z; Yang QX
    Int J Med Sci; 2014; 11(1):106-15. PubMed ID: 24396292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma.
    Zhou W; Feng X; Ren C; Jiang X; Liu W; Huang W; Liu Z; Li Z; Zeng L; Wang L; Zhu B; Shi J; Liu J; Zhang C; Liu Y; Yao K
    Mol Cancer; 2013 Jun; 12():53. PubMed ID: 23758864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA TGFBR2 acts as a ceRNA to suppress nasopharyngeal carcinoma progression by sponging miR-107.
    Li W; Lu H; Wang H; Ning X; Liu Q; Zhang H; Liu Z; Wang J; Zhao W; Gu Y; Li H; Sun X; Hu L; Wang D
    Cancer Lett; 2021 Feb; 499():301-313. PubMed ID: 33160003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AURKA, as a potential prognostic biomarker, regulates autophagy and immune infiltration in nasopharyngeal carcinoma.
    Jiang D; Chen H; Cao J; Chen Y; Huang J; Weng Y
    Immunobiology; 2023 Mar; 228(2):152314. PubMed ID: 36587494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway.
    Wu Q; Xiang M; Wang K; Chen Z; Long L; Tao Y; Liang Y; Yan Y; Xiao Z; Qiu S; Yi B
    Curr Cancer Drug Targets; 2020; 20(8):624-637. PubMed ID: 32329689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.